Developing an Explainable Prognostic Model for Acute Ischemic Stroke: Combining Clinical and Inflammatory Biomarkers With Machine Learning

Documenti analoghi

• Inflammatory Markers Mediate the Prognosis of Baseline Mismatch Volume and 90‐Day Outcomes in Acute Ischemic Stroke Patients
  di: Lianhong Ji, et al.
  Pubblicazione: (2026)
• Edaravone's Safety Profile in Acute Ischemic Stroke
  di: Laurence K. J. Batino, et al.
  Pubblicazione: (2024)
• Association and Comparative Analysis of Four Inflammatory Indices With 90‐Day Outcomes in Acute Ischemic Stroke Patients Treated With Intravenous Thrombolysis
  di: Xinping Bai, et al.
  Pubblicazione: (2026)
• The Mediating Effect of Inflammatory Biomarkers in the Associations Between Sarcoidosis and Incident Ischemic Stroke: A Prospective Cohort Study
  di: Zihong Bai, et al.
  Pubblicazione: (2026)
• Analysis of the Incidence and Influencing Factors of Depression in the Acute Stage of Ischemic Stroke: A Retrospective Clinical Study
  di: Xiao Zhou, et al.
  Pubblicazione: (2025)